nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Teniposide—lymphatic system cancer	0.304	1	CrCtD
Etoposide—Topoisomerase Inhibitors—Teniposide—lymphatic system cancer	0.194	0.569	CiPCiCtD
Etoposide—Podofilox—Teniposide—lymphatic system cancer	0.176	1	CrCrCtD
Etoposide—Topoisomerase Inhibitors—Mitoxantrone—lymphatic system cancer	0.147	0.431	CiPCiCtD
Etoposide—ABCC6—Teniposide—lymphatic system cancer	0.027	0.187	CbGbCtD
Etoposide—ABCC10—Cytarabine—lymphatic system cancer	0.021	0.145	CbGbCtD
Etoposide—TOP2A—Teniposide—lymphatic system cancer	0.0144	0.0994	CbGbCtD
Etoposide—TOP2A—Mitoxantrone—lymphatic system cancer	0.0101	0.0695	CbGbCtD
Etoposide—ABCC10—Vincristine—lymphatic system cancer	0.00995	0.0687	CbGbCtD
Etoposide—ABCC3—Vincristine—lymphatic system cancer	0.00625	0.0432	CbGbCtD
Etoposide—ABCC10—Methotrexate—lymphatic system cancer	0.00602	0.0416	CbGbCtD
Etoposide—ABCC1—Mitoxantrone—lymphatic system cancer	0.00558	0.0385	CbGbCtD
Etoposide—ABCG2—Teniposide—lymphatic system cancer	0.00534	0.0369	CbGbCtD
Etoposide—ABCC1—Vincristine—lymphatic system cancer	0.00384	0.0265	CbGbCtD
Etoposide—ABCC3—Methotrexate—lymphatic system cancer	0.00379	0.0261	CbGbCtD
Etoposide—ABCG2—Mitoxantrone—lymphatic system cancer	0.00373	0.0258	CbGbCtD
Etoposide—CYP1A2—Carmustine—lymphatic system cancer	0.00328	0.0226	CbGbCtD
Etoposide—CYP3A5—Teniposide—lymphatic system cancer	0.00296	0.0204	CbGbCtD
Etoposide—ABCC2—Vincristine—lymphatic system cancer	0.00284	0.0196	CbGbCtD
Etoposide—CYP2E1—Mitoxantrone—lymphatic system cancer	0.00266	0.0184	CbGbCtD
Etoposide—ABCG2—Vincristine—lymphatic system cancer	0.00257	0.0177	CbGbCtD
Etoposide—ABCC1—Methotrexate—lymphatic system cancer	0.00233	0.0161	CbGbCtD
Etoposide—ABCC2—Methotrexate—lymphatic system cancer	0.00172	0.0119	CbGbCtD
Etoposide—ABCG2—Methotrexate—lymphatic system cancer	0.00156	0.0107	CbGbCtD
Etoposide—CYP3A5—Vincristine—lymphatic system cancer	0.00142	0.00983	CbGbCtD
Etoposide—ABCB1—Mitoxantrone—lymphatic system cancer	0.00135	0.0093	CbGbCtD
Etoposide—CYP3A4—Cytarabine—lymphatic system cancer	0.00117	0.00809	CbGbCtD
Etoposide—CYP3A4—Teniposide—lymphatic system cancer	0.00115	0.00796	CbGbCtD
Etoposide—ABCB1—Vincristine—lymphatic system cancer	0.000927	0.0064	CbGbCtD
Etoposide—CYP3A4—Mitoxantrone—lymphatic system cancer	0.000807	0.00557	CbGbCtD
Etoposide—ABCB1—Methotrexate—lymphatic system cancer	0.000561	0.00387	CbGbCtD
Etoposide—CYP3A4—Vincristine—lymphatic system cancer	0.000555	0.00383	CbGbCtD
Etoposide—ABCC6—Podofilox—Teniposide—lymphatic system cancer	0.000381	0.504	CbGdCrCtD
Etoposide—TOP2A—Podofilox—Teniposide—lymphatic system cancer	6.91e-05	0.0914	CbGdCrCtD
Etoposide—TOP2A—Vindesine—Vincristine—lymphatic system cancer	6.52e-05	0.0862	CbGdCrCtD
Etoposide—Renal failure—Mitoxantrone—lymphatic system cancer	4.41e-05	0.00131	CcSEcCtD
Etoposide—Nausea—Mechlorethamine—lymphatic system cancer	4.41e-05	0.00131	CcSEcCtD
Etoposide—Myocardial infarction—Mitoxantrone—lymphatic system cancer	4.4e-05	0.0013	CcSEcCtD
Etoposide—Alopecia—Bleomycin—lymphatic system cancer	4.38e-05	0.0013	CcSEcCtD
Etoposide—Jaundice—Mitoxantrone—lymphatic system cancer	4.37e-05	0.0013	CcSEcCtD
Etoposide—Stomatitis—Mitoxantrone—lymphatic system cancer	4.37e-05	0.0013	CcSEcCtD
Etoposide—Urticaria—Teniposide—lymphatic system cancer	4.34e-05	0.00129	CcSEcCtD
Etoposide—Abdominal pain—Teniposide—lymphatic system cancer	4.32e-05	0.00128	CcSEcCtD
Etoposide—Body temperature increased—Teniposide—lymphatic system cancer	4.32e-05	0.00128	CcSEcCtD
Etoposide—Paraesthesia—Fludarabine—lymphatic system cancer	4.32e-05	0.00128	CcSEcCtD
Etoposide—Hypoaesthesia—Carmustine—lymphatic system cancer	4.31e-05	0.00128	CcSEcCtD
Etoposide—Hyperuricaemia—Methotrexate—lymphatic system cancer	4.3e-05	0.00128	CcSEcCtD
Etoposide—Dyspnoea—Fludarabine—lymphatic system cancer	4.28e-05	0.00127	CcSEcCtD
Etoposide—Ulcer—Methotrexate—lymphatic system cancer	4.22e-05	0.00125	CcSEcCtD
Etoposide—Agranulocytosis—Mitoxantrone—lymphatic system cancer	4.18e-05	0.00124	CcSEcCtD
Etoposide—Decreased appetite—Fludarabine—lymphatic system cancer	4.18e-05	0.00124	CcSEcCtD
Etoposide—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	4.15e-05	0.00123	CcSEcCtD
Etoposide—Fatigue—Fludarabine—lymphatic system cancer	4.14e-05	0.00123	CcSEcCtD
Etoposide—Inflammation—Methotrexate—lymphatic system cancer	4.12e-05	0.00122	CcSEcCtD
Etoposide—TOP2A—Vinorelbine—Vincristine—lymphatic system cancer	4.12e-05	0.0544	CbGdCrCtD
Etoposide—Hypoaesthesia—Vincristine—lymphatic system cancer	4.11e-05	0.00122	CcSEcCtD
Etoposide—Pain—Fludarabine—lymphatic system cancer	4.11e-05	0.00122	CcSEcCtD
Etoposide—Constipation—Fludarabine—lymphatic system cancer	4.11e-05	0.00122	CcSEcCtD
Etoposide—Urinary tract disorder—Vincristine—lymphatic system cancer	4.08e-05	0.00121	CcSEcCtD
Etoposide—Blood uric acid increased—Methotrexate—lymphatic system cancer	4.07e-05	0.00121	CcSEcCtD
Etoposide—Urethral disorder—Vincristine—lymphatic system cancer	4.05e-05	0.0012	CcSEcCtD
Etoposide—Eye disorder—Carmustine—lymphatic system cancer	4.05e-05	0.0012	CcSEcCtD
Etoposide—Hypersensitivity—Teniposide—lymphatic system cancer	4.03e-05	0.0012	CcSEcCtD
Etoposide—Flushing—Carmustine—lymphatic system cancer	4.02e-05	0.00119	CcSEcCtD
Etoposide—Ill-defined disorder—Bleomycin—lymphatic system cancer	4.01e-05	0.00119	CcSEcCtD
Etoposide—Anaemia—Bleomycin—lymphatic system cancer	3.99e-05	0.00118	CcSEcCtD
Etoposide—Feeling abnormal—Fludarabine—lymphatic system cancer	3.96e-05	0.00118	CcSEcCtD
Etoposide—Asthenia—Teniposide—lymphatic system cancer	3.92e-05	0.00116	CcSEcCtD
Etoposide—Malaise—Bleomycin—lymphatic system cancer	3.89e-05	0.00116	CcSEcCtD
Etoposide—Pruritus—Teniposide—lymphatic system cancer	3.87e-05	0.00115	CcSEcCtD
Etoposide—Leukopenia—Bleomycin—lymphatic system cancer	3.86e-05	0.00115	CcSEcCtD
Etoposide—Cardiac disorder—Vincristine—lymphatic system cancer	3.84e-05	0.00114	CcSEcCtD
Etoposide—Alopecia—Carmustine—lymphatic system cancer	3.83e-05	0.00114	CcSEcCtD
Etoposide—Skin exfoliation—Methotrexate—lymphatic system cancer	3.81e-05	0.00113	CcSEcCtD
Etoposide—Body temperature increased—Fludarabine—lymphatic system cancer	3.8e-05	0.00113	CcSEcCtD
Etoposide—Cough—Bleomycin—lymphatic system cancer	3.77e-05	0.00112	CcSEcCtD
Etoposide—Angiopathy—Vincristine—lymphatic system cancer	3.75e-05	0.00111	CcSEcCtD
Etoposide—Diarrhoea—Teniposide—lymphatic system cancer	3.74e-05	0.00111	CcSEcCtD
Etoposide—Mediastinal disorder—Vincristine—lymphatic system cancer	3.72e-05	0.00111	CcSEcCtD
Etoposide—Chest pain—Bleomycin—lymphatic system cancer	3.68e-05	0.00109	CcSEcCtD
Etoposide—Alopecia—Vincristine—lymphatic system cancer	3.65e-05	0.00108	CcSEcCtD
Etoposide—Back pain—Carmustine—lymphatic system cancer	3.65e-05	0.00108	CcSEcCtD
Etoposide—Discomfort—Bleomycin—lymphatic system cancer	3.63e-05	0.00108	CcSEcCtD
Etoposide—Chills—Mitoxantrone—lymphatic system cancer	3.61e-05	0.00107	CcSEcCtD
Etoposide—Mouth ulceration—Methotrexate—lymphatic system cancer	3.61e-05	0.00107	CcSEcCtD
Etoposide—Alopecia—Mitoxantrone—lymphatic system cancer	3.56e-05	0.00106	CcSEcCtD
Etoposide—Confusional state—Bleomycin—lymphatic system cancer	3.55e-05	0.00105	CcSEcCtD
Etoposide—Hypersensitivity—Fludarabine—lymphatic system cancer	3.54e-05	0.00105	CcSEcCtD
Etoposide—Anaphylactic shock—Bleomycin—lymphatic system cancer	3.52e-05	0.00105	CcSEcCtD
Etoposide—Infection—Bleomycin—lymphatic system cancer	3.5e-05	0.00104	CcSEcCtD
Etoposide—Anaemia—Carmustine—lymphatic system cancer	3.48e-05	0.00103	CcSEcCtD
Etoposide—Back pain—Vincristine—lymphatic system cancer	3.48e-05	0.00103	CcSEcCtD
Etoposide—Vomiting—Teniposide—lymphatic system cancer	3.48e-05	0.00103	CcSEcCtD
Etoposide—Sepsis—Methotrexate—lymphatic system cancer	3.47e-05	0.00103	CcSEcCtD
Etoposide—Thrombocytopenia—Bleomycin—lymphatic system cancer	3.45e-05	0.00102	CcSEcCtD
Etoposide—Asthenia—Fludarabine—lymphatic system cancer	3.45e-05	0.00102	CcSEcCtD
Etoposide—Rash—Teniposide—lymphatic system cancer	3.45e-05	0.00102	CcSEcCtD
Etoposide—Dermatitis—Teniposide—lymphatic system cancer	3.44e-05	0.00102	CcSEcCtD
Etoposide—Dysgeusia—Mitoxantrone—lymphatic system cancer	3.43e-05	0.00102	CcSEcCtD
Etoposide—Headache—Teniposide—lymphatic system cancer	3.43e-05	0.00102	CcSEcCtD
Etoposide—Pruritus—Fludarabine—lymphatic system cancer	3.4e-05	0.00101	CcSEcCtD
Etoposide—Back pain—Mitoxantrone—lymphatic system cancer	3.39e-05	0.00101	CcSEcCtD
Etoposide—Leukopenia—Carmustine—lymphatic system cancer	3.37e-05	0.001	CcSEcCtD
Etoposide—Anorexia—Bleomycin—lymphatic system cancer	3.36e-05	0.000997	CcSEcCtD
Etoposide—Anaemia—Vincristine—lymphatic system cancer	3.33e-05	0.000987	CcSEcCtD
Etoposide—Hypotension—Bleomycin—lymphatic system cancer	3.29e-05	0.000978	CcSEcCtD
Etoposide—Diarrhoea—Fludarabine—lymphatic system cancer	3.29e-05	0.000976	CcSEcCtD
Etoposide—Convulsion—Carmustine—lymphatic system cancer	3.27e-05	0.00097	CcSEcCtD
Etoposide—Hypertension—Carmustine—lymphatic system cancer	3.25e-05	0.000966	CcSEcCtD
Etoposide—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	3.25e-05	0.000965	CcSEcCtD
Etoposide—Nausea—Teniposide—lymphatic system cancer	3.25e-05	0.000964	CcSEcCtD
Etoposide—Anaemia—Mitoxantrone—lymphatic system cancer	3.24e-05	0.000961	CcSEcCtD
Etoposide—Vertigo—Vincristine—lymphatic system cancer	3.23e-05	0.00096	CcSEcCtD
Etoposide—Leukopenia—Vincristine—lymphatic system cancer	3.22e-05	0.000956	CcSEcCtD
Etoposide—Chest pain—Carmustine—lymphatic system cancer	3.21e-05	0.000953	CcSEcCtD
Etoposide—Paraesthesia—Bleomycin—lymphatic system cancer	3.16e-05	0.000939	CcSEcCtD
Etoposide—Malaise—Mitoxantrone—lymphatic system cancer	3.16e-05	0.000938	CcSEcCtD
Etoposide—Dyspnoea—Bleomycin—lymphatic system cancer	3.14e-05	0.000933	CcSEcCtD
Etoposide—Leukopenia—Mitoxantrone—lymphatic system cancer	3.14e-05	0.000931	CcSEcCtD
Etoposide—Convulsion—Vincristine—lymphatic system cancer	3.12e-05	0.000925	CcSEcCtD
Etoposide—TOP2A—Cladribine—Fludarabine—lymphatic system cancer	3.11e-05	0.0412	CbGdCrCtD
Etoposide—Hypertension—Vincristine—lymphatic system cancer	3.11e-05	0.000922	CcSEcCtD
Etoposide—Confusional state—Carmustine—lymphatic system cancer	3.1e-05	0.000921	CcSEcCtD
Etoposide—Decreased appetite—Bleomycin—lymphatic system cancer	3.06e-05	0.000909	CcSEcCtD
Etoposide—Cough—Mitoxantrone—lymphatic system cancer	3.06e-05	0.000908	CcSEcCtD
Etoposide—Infection—Carmustine—lymphatic system cancer	3.06e-05	0.000907	CcSEcCtD
Etoposide—Vomiting—Fludarabine—lymphatic system cancer	3.06e-05	0.000907	CcSEcCtD
Etoposide—Convulsion—Mitoxantrone—lymphatic system cancer	3.04e-05	0.000901	CcSEcCtD
Etoposide—Rash—Fludarabine—lymphatic system cancer	3.03e-05	0.0009	CcSEcCtD
Etoposide—Dermatitis—Fludarabine—lymphatic system cancer	3.03e-05	0.000899	CcSEcCtD
Etoposide—Hypertension—Mitoxantrone—lymphatic system cancer	3.03e-05	0.000898	CcSEcCtD
Etoposide—Pain—Bleomycin—lymphatic system cancer	3.01e-05	0.000895	CcSEcCtD
Etoposide—Thrombocytopenia—Carmustine—lymphatic system cancer	3.01e-05	0.000894	CcSEcCtD
Etoposide—Headache—Fludarabine—lymphatic system cancer	3.01e-05	0.000894	CcSEcCtD
Etoposide—Tachycardia—Carmustine—lymphatic system cancer	3e-05	0.000891	CcSEcCtD
Etoposide—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	3e-05	0.000889	CcSEcCtD
Etoposide—Chest pain—Mitoxantrone—lymphatic system cancer	2.98e-05	0.000886	CcSEcCtD
Etoposide—Discomfort—Mitoxantrone—lymphatic system cancer	2.95e-05	0.000875	CcSEcCtD
Etoposide—Anaphylactic shock—Vincristine—lymphatic system cancer	2.94e-05	0.000872	CcSEcCtD
Etoposide—Anorexia—Carmustine—lymphatic system cancer	2.93e-05	0.000871	CcSEcCtD
Etoposide—Infection—Vincristine—lymphatic system cancer	2.92e-05	0.000866	CcSEcCtD
Etoposide—Feeling abnormal—Bleomycin—lymphatic system cancer	2.9e-05	0.000862	CcSEcCtD
Etoposide—Confusional state—Mitoxantrone—lymphatic system cancer	2.88e-05	0.000856	CcSEcCtD
Etoposide—TOP2A—Clofarabine—Fludarabine—lymphatic system cancer	2.88e-05	0.0381	CbGdCrCtD
Etoposide—Thrombocytopenia—Vincristine—lymphatic system cancer	2.87e-05	0.000854	CcSEcCtD
Etoposide—Hypotension—Carmustine—lymphatic system cancer	2.87e-05	0.000853	CcSEcCtD
Etoposide—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	2.86e-05	0.000849	CcSEcCtD
Etoposide—Nausea—Fludarabine—lymphatic system cancer	2.85e-05	0.000848	CcSEcCtD
Etoposide—Infection—Mitoxantrone—lymphatic system cancer	2.84e-05	0.000843	CcSEcCtD
Etoposide—Hyperhidrosis—Vincristine—lymphatic system cancer	2.84e-05	0.000843	CcSEcCtD
Etoposide—TOP2A—Vinblastine—Vincristine—lymphatic system cancer	2.83e-05	0.0374	CbGdCrCtD
Etoposide—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	2.8e-05	0.000831	CcSEcCtD
Etoposide—Urticaria—Bleomycin—lymphatic system cancer	2.8e-05	0.000831	CcSEcCtD
Etoposide—Anorexia—Vincristine—lymphatic system cancer	2.8e-05	0.000831	CcSEcCtD
Etoposide—Tachycardia—Mitoxantrone—lymphatic system cancer	2.79e-05	0.000829	CcSEcCtD
Etoposide—Body temperature increased—Bleomycin—lymphatic system cancer	2.79e-05	0.000827	CcSEcCtD
Etoposide—Skin disorder—Mitoxantrone—lymphatic system cancer	2.78e-05	0.000825	CcSEcCtD
Etoposide—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	2.76e-05	0.000821	CcSEcCtD
Etoposide—Paraesthesia—Carmustine—lymphatic system cancer	2.76e-05	0.00082	CcSEcCtD
Etoposide—Hypotension—Vincristine—lymphatic system cancer	2.74e-05	0.000815	CcSEcCtD
Etoposide—Dyspnoea—Carmustine—lymphatic system cancer	2.74e-05	0.000814	CcSEcCtD
Etoposide—Somnolence—Carmustine—lymphatic system cancer	2.73e-05	0.000812	CcSEcCtD
Etoposide—Anorexia—Mitoxantrone—lymphatic system cancer	2.73e-05	0.000809	CcSEcCtD
Etoposide—TOP2A—Clofarabine—Cytarabine—lymphatic system cancer	2.72e-05	0.0359	CbGdCrCtD
Etoposide—Decreased appetite—Carmustine—lymphatic system cancer	2.67e-05	0.000794	CcSEcCtD
Etoposide—Hypotension—Mitoxantrone—lymphatic system cancer	2.67e-05	0.000793	CcSEcCtD
Etoposide—Gastrointestinal disorder—Carmustine—lymphatic system cancer	2.66e-05	0.000788	CcSEcCtD
Etoposide—Paraesthesia—Vincristine—lymphatic system cancer	2.64e-05	0.000783	CcSEcCtD
Etoposide—Pain—Carmustine—lymphatic system cancer	2.63e-05	0.000781	CcSEcCtD
Etoposide—Constipation—Carmustine—lymphatic system cancer	2.63e-05	0.000781	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	2.61e-05	0.000775	CcSEcCtD
Etoposide—Hypersensitivity—Bleomycin—lymphatic system cancer	2.6e-05	0.000771	CcSEcCtD
Etoposide—Paraesthesia—Mitoxantrone—lymphatic system cancer	2.57e-05	0.000762	CcSEcCtD
Etoposide—Decreased appetite—Vincristine—lymphatic system cancer	2.55e-05	0.000758	CcSEcCtD
Etoposide—Dyspnoea—Mitoxantrone—lymphatic system cancer	2.55e-05	0.000757	CcSEcCtD
Etoposide—Somnolence—Mitoxantrone—lymphatic system cancer	2.54e-05	0.000755	CcSEcCtD
Etoposide—Gastrointestinal disorder—Vincristine—lymphatic system cancer	2.54e-05	0.000753	CcSEcCtD
Etoposide—Feeling abnormal—Carmustine—lymphatic system cancer	2.53e-05	0.000753	CcSEcCtD
Etoposide—Fatigue—Vincristine—lymphatic system cancer	2.53e-05	0.000752	CcSEcCtD
Etoposide—Asthenia—Bleomycin—lymphatic system cancer	2.53e-05	0.000751	CcSEcCtD
Etoposide—TOP2A—Gemcitabine—Cytarabine—lymphatic system cancer	2.52e-05	0.0333	CbGdCrCtD
Etoposide—Gastrointestinal pain—Carmustine—lymphatic system cancer	2.52e-05	0.000747	CcSEcCtD
Etoposide—Pain—Vincristine—lymphatic system cancer	2.51e-05	0.000745	CcSEcCtD
Etoposide—Constipation—Vincristine—lymphatic system cancer	2.51e-05	0.000745	CcSEcCtD
Etoposide—Pruritus—Bleomycin—lymphatic system cancer	2.49e-05	0.00074	CcSEcCtD
Etoposide—Decreased appetite—Mitoxantrone—lymphatic system cancer	2.49e-05	0.000738	CcSEcCtD
Etoposide—Fatigue—Mitoxantrone—lymphatic system cancer	2.47e-05	0.000732	CcSEcCtD
Etoposide—TOP2A—Cytarabine—Fludarabine—lymphatic system cancer	2.45e-05	0.0324	CbGdCrCtD
Etoposide—Pain—Mitoxantrone—lymphatic system cancer	2.45e-05	0.000726	CcSEcCtD
Etoposide—Constipation—Mitoxantrone—lymphatic system cancer	2.45e-05	0.000726	CcSEcCtD
Etoposide—Abdominal pain—Carmustine—lymphatic system cancer	2.43e-05	0.000722	CcSEcCtD
Etoposide—Body temperature increased—Carmustine—lymphatic system cancer	2.43e-05	0.000722	CcSEcCtD
Etoposide—Gastrointestinal pain—Vincristine—lymphatic system cancer	2.4e-05	0.000713	CcSEcCtD
Etoposide—Pancytopenia—Methotrexate—lymphatic system cancer	2.38e-05	0.000706	CcSEcCtD
Etoposide—Feeling abnormal—Mitoxantrone—lymphatic system cancer	2.36e-05	0.0007	CcSEcCtD
Etoposide—Neutropenia—Methotrexate—lymphatic system cancer	2.34e-05	0.000696	CcSEcCtD
Etoposide—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	2.34e-05	0.000694	CcSEcCtD
Etoposide—Body temperature increased—Vincristine—lymphatic system cancer	2.32e-05	0.000689	CcSEcCtD
Etoposide—Abdominal pain—Vincristine—lymphatic system cancer	2.32e-05	0.000689	CcSEcCtD
Etoposide—Urticaria—Mitoxantrone—lymphatic system cancer	2.27e-05	0.000674	CcSEcCtD
Etoposide—Hypersensitivity—Carmustine—lymphatic system cancer	2.27e-05	0.000673	CcSEcCtD
Etoposide—Abdominal pain—Mitoxantrone—lymphatic system cancer	2.26e-05	0.000671	CcSEcCtD
Etoposide—Body temperature increased—Mitoxantrone—lymphatic system cancer	2.26e-05	0.000671	CcSEcCtD
Etoposide—Pneumonia—Methotrexate—lymphatic system cancer	2.25e-05	0.000667	CcSEcCtD
Etoposide—Vomiting—Bleomycin—lymphatic system cancer	2.24e-05	0.000665	CcSEcCtD
Etoposide—Infestation NOS—Methotrexate—lymphatic system cancer	2.23e-05	0.000663	CcSEcCtD
Etoposide—Infestation—Methotrexate—lymphatic system cancer	2.23e-05	0.000663	CcSEcCtD
Etoposide—Rash—Bleomycin—lymphatic system cancer	2.22e-05	0.00066	CcSEcCtD
Etoposide—Dermatitis—Bleomycin—lymphatic system cancer	2.22e-05	0.000659	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	2.21e-05	0.000658	CcSEcCtD
Etoposide—Asthenia—Carmustine—lymphatic system cancer	2.21e-05	0.000655	CcSEcCtD
Etoposide—Renal failure—Methotrexate—lymphatic system cancer	2.2e-05	0.000652	CcSEcCtD
Etoposide—Stomatitis—Methotrexate—lymphatic system cancer	2.18e-05	0.000646	CcSEcCtD
Etoposide—Hypersensitivity—Vincristine—lymphatic system cancer	2.16e-05	0.000642	CcSEcCtD
Etoposide—Hepatobiliary disease—Methotrexate—lymphatic system cancer	2.11e-05	0.000627	CcSEcCtD
Etoposide—Hypersensitivity—Mitoxantrone—lymphatic system cancer	2.11e-05	0.000626	CcSEcCtD
Etoposide—Asthenia—Vincristine—lymphatic system cancer	2.11e-05	0.000625	CcSEcCtD
Etoposide—Diarrhoea—Carmustine—lymphatic system cancer	2.1e-05	0.000625	CcSEcCtD
Etoposide—Nausea—Bleomycin—lymphatic system cancer	2.09e-05	0.000621	CcSEcCtD
Etoposide—Agranulocytosis—Methotrexate—lymphatic system cancer	2.08e-05	0.000619	CcSEcCtD
Etoposide—Asthenia—Mitoxantrone—lymphatic system cancer	2.05e-05	0.000609	CcSEcCtD
Etoposide—Dizziness—Carmustine—lymphatic system cancer	2.03e-05	0.000604	CcSEcCtD
Etoposide—Diarrhoea—Vincristine—lymphatic system cancer	2.01e-05	0.000596	CcSEcCtD
Etoposide—Urinary tract disorder—Methotrexate—lymphatic system cancer	1.98e-05	0.000588	CcSEcCtD
Etoposide—Urethral disorder—Methotrexate—lymphatic system cancer	1.97e-05	0.000584	CcSEcCtD
Etoposide—Diarrhoea—Mitoxantrone—lymphatic system cancer	1.96e-05	0.000581	CcSEcCtD
Etoposide—Vomiting—Carmustine—lymphatic system cancer	1.96e-05	0.000581	CcSEcCtD
Etoposide—Dizziness—Vincristine—lymphatic system cancer	1.94e-05	0.000576	CcSEcCtD
Etoposide—Rash—Carmustine—lymphatic system cancer	1.94e-05	0.000576	CcSEcCtD
Etoposide—Dermatitis—Carmustine—lymphatic system cancer	1.94e-05	0.000575	CcSEcCtD
Etoposide—Headache—Carmustine—lymphatic system cancer	1.93e-05	0.000572	CcSEcCtD
Etoposide—Erythema multiforme—Methotrexate—lymphatic system cancer	1.9e-05	0.000563	CcSEcCtD
Etoposide—Eye disorder—Methotrexate—lymphatic system cancer	1.87e-05	0.000556	CcSEcCtD
Etoposide—Vomiting—Vincristine—lymphatic system cancer	1.87e-05	0.000554	CcSEcCtD
Etoposide—Cardiac disorder—Methotrexate—lymphatic system cancer	1.86e-05	0.000553	CcSEcCtD
Etoposide—Rash—Vincristine—lymphatic system cancer	1.85e-05	0.00055	CcSEcCtD
Etoposide—Dermatitis—Vincristine—lymphatic system cancer	1.85e-05	0.000549	CcSEcCtD
Etoposide—Headache—Vincristine—lymphatic system cancer	1.84e-05	0.000546	CcSEcCtD
Etoposide—Nausea—Carmustine—lymphatic system cancer	1.83e-05	0.000542	CcSEcCtD
Etoposide—Angiopathy—Methotrexate—lymphatic system cancer	1.82e-05	0.00054	CcSEcCtD
Etoposide—Vomiting—Mitoxantrone—lymphatic system cancer	1.82e-05	0.00054	CcSEcCtD
Etoposide—Immune system disorder—Methotrexate—lymphatic system cancer	1.81e-05	0.000538	CcSEcCtD
Etoposide—Mediastinal disorder—Methotrexate—lymphatic system cancer	1.81e-05	0.000537	CcSEcCtD
Etoposide—Rash—Mitoxantrone—lymphatic system cancer	1.8e-05	0.000535	CcSEcCtD
Etoposide—Dermatitis—Mitoxantrone—lymphatic system cancer	1.8e-05	0.000535	CcSEcCtD
Etoposide—Chills—Methotrexate—lymphatic system cancer	1.8e-05	0.000534	CcSEcCtD
Etoposide—Headache—Mitoxantrone—lymphatic system cancer	1.79e-05	0.000532	CcSEcCtD
Etoposide—Alopecia—Methotrexate—lymphatic system cancer	1.77e-05	0.000526	CcSEcCtD
Etoposide—TOP2A—Azacitidine—Fludarabine—lymphatic system cancer	1.76e-05	0.0232	CbGdCrCtD
Etoposide—Nausea—Vincristine—lymphatic system cancer	1.74e-05	0.000518	CcSEcCtD
Etoposide—Dysgeusia—Methotrexate—lymphatic system cancer	1.71e-05	0.000508	CcSEcCtD
Etoposide—Nausea—Mitoxantrone—lymphatic system cancer	1.7e-05	0.000504	CcSEcCtD
Etoposide—Back pain—Methotrexate—lymphatic system cancer	1.69e-05	0.000501	CcSEcCtD
Etoposide—TOP2A—Azacitidine—Cytarabine—lymphatic system cancer	1.66e-05	0.0219	CbGdCrCtD
Etoposide—Ill-defined disorder—Methotrexate—lymphatic system cancer	1.62e-05	0.000481	CcSEcCtD
Etoposide—Anaemia—Methotrexate—lymphatic system cancer	1.61e-05	0.000479	CcSEcCtD
Etoposide—Malaise—Methotrexate—lymphatic system cancer	1.57e-05	0.000467	CcSEcCtD
Etoposide—Vertigo—Methotrexate—lymphatic system cancer	1.57e-05	0.000466	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—lymphatic system cancer	1.56e-05	0.000464	CcSEcCtD
Etoposide—Cough—Methotrexate—lymphatic system cancer	1.52e-05	0.000452	CcSEcCtD
Etoposide—Convulsion—Methotrexate—lymphatic system cancer	1.51e-05	0.000449	CcSEcCtD
Etoposide—Chest pain—Methotrexate—lymphatic system cancer	1.49e-05	0.000441	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	1.48e-05	0.000438	CcSEcCtD
Etoposide—Discomfort—Methotrexate—lymphatic system cancer	1.47e-05	0.000436	CcSEcCtD
Etoposide—Confusional state—Methotrexate—lymphatic system cancer	1.44e-05	0.000427	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—lymphatic system cancer	1.42e-05	0.000423	CcSEcCtD
Etoposide—Infection—Methotrexate—lymphatic system cancer	1.42e-05	0.00042	CcSEcCtD
Etoposide—Thrombocytopenia—Methotrexate—lymphatic system cancer	1.39e-05	0.000414	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—lymphatic system cancer	1.38e-05	0.000411	CcSEcCtD
Etoposide—Hyperhidrosis—Methotrexate—lymphatic system cancer	1.38e-05	0.000409	CcSEcCtD
Etoposide—Anorexia—Methotrexate—lymphatic system cancer	1.36e-05	0.000403	CcSEcCtD
Etoposide—Hypotension—Methotrexate—lymphatic system cancer	1.33e-05	0.000395	CcSEcCtD
Etoposide—Paraesthesia—Methotrexate—lymphatic system cancer	1.28e-05	0.00038	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—lymphatic system cancer	1.27e-05	0.000377	CcSEcCtD
Etoposide—Somnolence—Methotrexate—lymphatic system cancer	1.27e-05	0.000376	CcSEcCtD
Etoposide—Decreased appetite—Methotrexate—lymphatic system cancer	1.24e-05	0.000368	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	1.23e-05	0.000365	CcSEcCtD
Etoposide—Fatigue—Methotrexate—lymphatic system cancer	1.23e-05	0.000365	CcSEcCtD
Etoposide—Pain—Methotrexate—lymphatic system cancer	1.22e-05	0.000362	CcSEcCtD
Etoposide—Feeling abnormal—Methotrexate—lymphatic system cancer	1.17e-05	0.000349	CcSEcCtD
Etoposide—Gastrointestinal pain—Methotrexate—lymphatic system cancer	1.17e-05	0.000346	CcSEcCtD
Etoposide—Urticaria—Methotrexate—lymphatic system cancer	1.13e-05	0.000336	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—lymphatic system cancer	1.13e-05	0.000334	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—lymphatic system cancer	1.13e-05	0.000334	CcSEcCtD
Etoposide—Hypersensitivity—Methotrexate—lymphatic system cancer	1.05e-05	0.000312	CcSEcCtD
Etoposide—Asthenia—Methotrexate—lymphatic system cancer	1.02e-05	0.000303	CcSEcCtD
Etoposide—Pruritus—Methotrexate—lymphatic system cancer	1.01e-05	0.000299	CcSEcCtD
Etoposide—Diarrhoea—Methotrexate—lymphatic system cancer	9.75e-06	0.000289	CcSEcCtD
Etoposide—Dizziness—Methotrexate—lymphatic system cancer	9.42e-06	0.00028	CcSEcCtD
Etoposide—Vomiting—Methotrexate—lymphatic system cancer	9.06e-06	0.000269	CcSEcCtD
Etoposide—Rash—Methotrexate—lymphatic system cancer	8.98e-06	0.000267	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—lymphatic system cancer	8.98e-06	0.000266	CcSEcCtD
Etoposide—Headache—Methotrexate—lymphatic system cancer	8.93e-06	0.000265	CcSEcCtD
Etoposide—Nausea—Methotrexate—lymphatic system cancer	8.46e-06	0.000251	CcSEcCtD
